TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.

A M Gonzalez-Angulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.